Joseph E. Blais

2/F, 21 Sassoon Road
Hong Kong Special Administrative Region, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Completeness of EMERGE guideline reporting in observational studies of PCSK9 inhibitor medication adherence: a study within a systematic review.

Completeness of EMERGE guideline reporting in observational studies of PCSK9 inhibitor medication adherence: a study within a systematic review.

Journal: JBI evidence synthesis

Published: June 18, 2026

Real-world variability and factors associated with individual low-density-lipoprotein cholesterol response to different doses of atorvastatin, rosuvastatin, and simvastatin in 28,647 Chinese patients.

Real-world variability and factors associated with individual low-density-lipoprotein cholesterol response to different doses of atorvastatin, rosuvastatin, and simvastatin in 28,647 Chinese patients.

Journal: Atherosclerosis

Published: April 08, 2026

SARS-CoV-2 viral shedding and vaccination‑modified effects of oral antivirals in older COVID-19 patients: A retrospective cohort study in Hong Kong.

SARS-CoV-2 viral shedding and vaccination‑modified effects of oral antivirals in older COVID-19 patients: A retrospective cohort study in Hong Kong.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: April 07, 2026

Sex-Specific Lipid, Apolipoprotein B, and Lipoprotein(a) Responses to Berberine Based on 2 Randomized Placebo-Controlled Trials.

Sex-Specific Lipid, Apolipoprotein B, and Lipoprotein(a) Responses to Berberine Based on 2 Randomized Placebo-Controlled Trials.

Journal: JACC. Asia

Published: March 16, 2026

Combination therapy with moderate-intensity statins and ezetimibe and risk of incident PCI/CABG in atherosclerotic cardiovascular disease: a propensity-matched cohort study.

Combination therapy with moderate-intensity statins and ezetimibe and risk of incident PCI/CABG in atherosclerotic cardiovascular disease: a propensity-matched cohort study.

Journal: The Lancet regional health. Western Pacific

Published: February 22, 2026

Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk : A Target Trial Emulation Study.

Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk : A Target Trial Emulation Study.

Journal: Annals of internal medicine

Published: December 29, 2025

Building a culture of inquiry: a perspective on pharmacy education, practice, and research in Hong Kong.

Building a culture of inquiry: a perspective on pharmacy education, practice, and research in Hong Kong.

Journal: The International journal of pharmacy practice

Published: November 10, 2025

Adherence to PCSK9 Inhibitors in Clinical Practice: Systematic Review and Meta-Analysis of Observational Studies.

Adherence to PCSK9 Inhibitors in Clinical Practice: Systematic Review and Meta-Analysis of Observational Studies.

Journal: JACC. Advances

Published: October 31, 2025

Real-World Evidence on Prescribing Patterns and Lipid-Lowering Effectiveness of Monoclonal Antibody PCSK9 Inhibitors from Hong Kong.

Real-World Evidence on Prescribing Patterns and Lipid-Lowering Effectiveness of Monoclonal Antibody PCSK9 Inhibitors from Hong Kong.

Journal: European journal of preventive cardiology

Published: October 14, 2025

Consumption and expenditure on fidaxomicin and oral vancomycin for Clostridioides difficile infection: A 12-year longitudinal study of 43 countries and regions.

Consumption and expenditure on fidaxomicin and oral vancomycin for Clostridioides difficile infection: A 12-year longitudinal study of 43 countries and regions.

Journal: International journal of antimicrobial agents

Published: August 07, 2025

Blood pressure effects of SGLT2 inhibitors and GLP-1 receptor agonists: Mechanisms, trial evidence and Real-world data.

Blood pressure effects of SGLT2 inhibitors and GLP-1 receptor agonists: Mechanisms, trial evidence and Real-world data.

Journal: British journal of clinical pharmacology

Published: August 06, 2025

Risk of Ischaemic Stroke Varies With Antithrombotic Drugs Use in Proton Pump Inhibitor Users: A Self-Controlled Case Series Study.

Risk of Ischaemic Stroke Varies With Antithrombotic Drugs Use in Proton Pump Inhibitor Users: A Self-Controlled Case Series Study.

Journal: Pharmacoepidemiology and drug safety

Published: May 19, 2025

Showing 1-12 of 49

Last Updated: 09/26/2026